# Medifast (MED) — Earnings

MED · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/med/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.28 |
| EPS estimate | −$0.65 |
| EPS surprise | +56.92% |
| Revenue surprise | +5.07% |
| Revenue | $76.4M |
| Revenue estimate | $72.7M |
| Reported | Aug 3, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/910329/000162828026051928/med-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/9adc0f7c-8168-e1f3-186c-97a75662903f.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 3, 2026 | −$0.65 | −$0.28 | 56.92% | $72.7M | $76.4M |
| Q1 2026 | May 4, 2026 | −$0.52 | −$0.19 | 63.46% | $69.2M | $76.0M |
| Q4 2025 | Feb 17, 2026 | −$0.82 | −$0.55 | 32.93% | $71.4M | $75.1M |
| Q3 2025 | Nov 3, 2025 | −$0.36 | −$0.21 | 41.67% | $89.7M | $89.4M |
| Q2 2025 | Aug 4, 2025 | −$0.19 | $0.40 | 310.95% | $101.8M | $105.6M |
| Q1 2025 | Apr 28, 2025 | −$0.25 | −$0.03 | 86.60% | $116.4M | $115.7M |
| Q4 2024 | Feb 18, 2025 | −$0.15 | $0.10 | 166.67% | $118.0M | $119.0M |
| Q3 2024 | Nov 4, 2024 | −$0.19 | $0.35 | 284.21% | $138.2M | $140.2M |
| Q2 2024 | Aug 5, 2024 | $0.39 | $0.92 | 136.75% | $174.1M | $168.6M |
| Q1 2024 | Apr 29, 2024 | $0.80 | $0.66 | -17.75% | $173.4M | $174.7M |
| Q4 2023 | Feb 20, 2024 | $0.96 | $1.09 | 13.28% | $184.2M | $191.0M |
| Q3 2023 | Nov 6, 2023 | $1.07 | $2.12 | 99.06% | $232.1M | $235.9M |
| Q2 2023 | Aug 7, 2023 | $1.44 | $2.77 | 92.36% | $270.2M | $296.2M |
| Q1 2023 | May 1, 2023 | $2.40 | $3.67 | 52.92% | $319.5M | $349.0M |
| Q4 2022 | Feb 21, 2023 | $2.22 | $3.70 | 66.98% | $330.1M | $337.2M |
| Q3 2022 | Nov 3, 2022 | $1.91 | $3.32 | 73.82% | $349.3M | $390.4M |
| Q2 2022 | Aug 3, 2022 | $3.28 | $3.87 | 18.17% | $455.0M | $453.3M |
| Q1 2022 | May 2, 2022 | $3.57 | $3.59 | 0.56% | $403.3M | $417.6M |
| Q4 2021 | Feb 23, 2022 | $2.65 | $2.91 | 9.67% | $375.8M | $377.8M |
| Q3 2021 | Nov 4, 2021 | $3.08 | $3.56 | 15.58% | $405.7M | $413.4M |

## Frequently Asked Questions

### When did Medifast (MED) last report earnings?

Medifast last reported on Aug 3, 2026, covering fiscal Q2 2026.

### Did MED beat earnings estimates?

Yes. Medifast reported EPS of −$0.28 for Q2 2026 against a −$0.65 estimate — a 56.92% beat.

### How much revenue did MED report last quarter?

Medifast reported $76.4M in revenue for Q2 2026, against a consensus estimate of $72.7M.

## Similar Stocks

- [NOMD](https://www.lighthorse.io/tickers/nomd) — Nomad Foods Limited Ordinary Shares
- [LW](https://www.lighthorse.io/tickers/lw) — Lamb Weston Holdings, Inc. Common Stock

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).